SCHEMBL7547685

SCHEMBL7547685

Clc1ccc2nc(-c3cccc(CNCCN4CCCCC4)c3)[nH]c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.56
MAP4K4 O95819 2/20 0.50
TP53 P04637 2/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
FTO Q9C0B1 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
BACE1 P56817 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
DRD2 P14416 3/20 0.46
DRD4 P21917 2/20 0.46
DRD3 P35462 2/20 0.46
DPP7 Q9UHL4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7553583 0.92 MAP4K4 (0.48) ACHEMAP4K4HDAC6HRH4DRD2
SCHEMBL7548837 0.89 CCR2 (0.54) ACHEMAP4K4HDAC6DPP7CNR1
SCHEMBL7550044 0.89 ACHE (0.65) ACHETP53HPGDKDM4EMEN1
SCHEMBL7549696 0.88 ACHE (0.53) ACHEMAP4K4TP53HPGDKDM4E
SCHEMBL7549558 0.84 MAP4K4 (0.48) ACHEMAP4K4HPGDKDM4EALDH1A1
SCHEMBL7554505 0.82 MAP4K4 (0.48) ACHEMAP4K4HPGDKDM4EALDH1A1
SCHEMBL7553609 0.81 ACHE (0.52) ACHETP53HPGDKDM4EMEN1
SCHEMBL7546717 0.81 ACHE (0.54) ACHEHDAC6HRH4DRD2DRD3
SCHEMBL7554493 0.80 MAP4K4 (0.52) ACHEMAP4K4HPGDKDM4EALDH1A1
SCHEMBL7554554 0.79 MAP4K4 (0.48) MAP4K4DPP7ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099054-A1 2-phenyl benzimidazole derivatives as MCP-1 antagonists WARNER-LAMBERT COMPANY (US) 2002-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099054-A1 2-phenyl benzimidazole derivatives as MCP-1 antagonists CCR1, CCR2, CCR8 ACHE 4652/4885MAP4K4 1964/4885TP53 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.